Spectral Medical Inc T.EDT

Alternate Symbol(s): EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.

TSX:EDT - Post by User

Spectral Medical Inc > Paradigm Research Report on Spectral

<< Previous

Bullboard Posts

Next >>

Post by TechOneon Mar 20, 2024 12:49pm

209 Views

Post# 35943119

Paradigm Research Report on Spectral

So I had the bright idea of sending an email to the author of the report since his email id is listed on Spectra's website..

And lo and behold I get a prompt auto reply to my email.. But look at the date quoted in the reply.. I wonder if he is still with Paradigm or not.. Oh well.. I tried..

Thank you for your email. I’ll be out of the office until Monday, December 18, so expect a delay in getting back to you.

<< Previous

Bullboard Posts

Next >>

Eminent acquires promising Nevada gold project